SCHEMBL976198

SCHEMBL976198

CC(C)(CCCCNc1ccccc1)O[SiH3]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.39
KCNH3 Q9ULD8 3/20 0.37
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
TSHR P16473 1/20 0.34
PPARG P37231 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
ACHE P22303 2/20 0.33
BCHE P06276 1/20 0.33
DRD4 P21917 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL974894 0.97 MAPT (0.53) MAPTALDH1A1L3MBTL1KCNH3HDAC3
SCHEMBL4264763 0.89 MAPT (0.47) MAPTALDH1A1L3MBTL1KCNH3TSHR
SCHEMBL978044 0.78 SIGMAR1 (0.41) MAPTALDH1A1L3MBTL1TSHRCYP1A2
SCHEMBL16714770 0.78 MAOA (0.61) MAPTHDAC3HDAC1HDAC2NCOR2
SCHEMBL4970157 0.77 ALDH1A1 (0.89) MAPTALDH1A1L3MBTL1KCNH3HDAC3
SCHEMBL16714737 0.75 MAOA (0.56) MAPTHDAC3HDAC1HDAC2NCOR2
SCHEMBL11759173 0.74 ALDH1A1 (0.84) MAPTALDH1A1L3MBTL1KCNH3HDAC3
SCHEMBL4643729 0.74 ALDH1A1 (0.84) MAPTALDH1A1L3MBTL1KCNH3HDAC3
SCHEMBL14968385 0.74 ALDH1A1 (0.84) MAPTALDH1A1L3MBTL1KCNH3HDAC3
SCHEMBL4104788 0.74 ALDH1A1 (0.84) MAPTALDH1A1L3MBTL1KCNH3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289898-B1 Melamine-functional organosilicon compound and making method SHINETSU CHEMICAL CO (JP) 2017-05-03 EP disclosed
US-8263766-B2 Melamine-functional organosilicon compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-09-11 US disclosed
EP-2289898-A1 Melamine-Functional organosilicon compound and making method Shin-Etsu Chemical Co., Ltd. (JP) 2011-03-02 EP disclosed
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD MEN1, MSH6, PRMT6 MAPT 1317/4885ALDH1A1 3030/4885L3MBTL1 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.